Clinical trials
Phase 2/3 Ovarian Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Completed | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Pierian Biosciences | 2 |
| Daiichi Sankyo | 1 |
| GE Healthcare | 1 |
| Menarini Group | 1 |
| Novita Pharmaceuticals, Inc. | 1 |
| Sanofi | 1 |
| Sutro Biopharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 10 |
| Fallopian Tube Neoplasms | 5 |
| Peritoneal Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Ascites | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Colorectal Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.